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Human recombinant umor necrosis factor-a (TNF) was found to stimulate the production of prostaglandins (PG) by 
cultured rat mesangial cells. This effect was demonstrable from 6 h, was dose dependent and affected the synthesis of 
PGE,, PGF,,, and 6-keto-PGF,.. It required both RNA and protein synthesis but was notassociated with a modification 
of cell proliferation. TNF also stimulated adenosine 3’-5’ cyclic monophosphate (CAMP) levels in the mesangial cell cul- 
ture medium. Indomethacin suppressed the effect of TNF on PGs but only reduced that on CAMP, indicating that PG 
production partly mediates the increase in CAMP. These findings demonstrate that mesangial cells can be a target for 
TNF and that the mechanism of TNF action includes stimulation of both PG production and CAMP levels. 
Tumor necrosis factor; Prostaglandin; Adenosine cyclic monophosphate; Glomerular mesangium 
1. INTRODUCTION 
Tumor necrosis factor is a monocyte/ 
macrophage-derived protein which induces a varie- 
ty of effects on cell functions, including modula- 
tion of proliferation rate, production of 
interleukin 1 (IL-l), PGE2, and collagenase, as 
well as induction of surface antigens [l]. Because 
infiltration of glomeruli by monocytes/ 
macrophages i  associated with local production of 
TNF in nephrotoxic serum nephritis [2,3], the 
question arises whether TNF could interact with 
glomerular cells and modify their functions. In this 
model of experimental glomerulonephritis, 
mesangial cell proliferation [4] and enhanced PG 
production [5] have been shown to occur following 
glomerular macrophage accumulation. Moreover, 
local PGEz synthesis results in an increase of the 
CAMP content of glomeruli [6], thereby inducing a 
fall in the ultrafiltration coefficient [7]. We 
therefore elected to determine the effects of human 
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recombinant TNF on the proliferation rate of 
cultured rat masangial cells and on their synthesis 
of both CAMP and PGs, including PGE2, PGFh 
and 6-keto-PGFi,, the stable end-product of 
PGI2, which are the main metabolites of the 
cyclooxygenase pathway in these cells [8]. 
2. MATERIALS AND METHODS 
2.1. Mesangial cell culture 
Mesangial cells were cultured from isolated rat glomeruli ac- 
cording to [9]. Briefly, glomeruli were prepared from the renal 
cortices of Sprague-Dawley rats by sieving techniques and dif- 
ferential centrifugations. After treatment by 300 U/ml of col- 
lagenase (300 U/mg; Sigma, St. Louis, MO) for 30 min at 
37”C, glomeruli were resuspended in RPM1 1640 medium (Flow 
Laboratories, Irvine, UK), buffered with 20 mM 
N-2-hydroxyethylpiperazine-N’-2-ethanesulfonic acid (Hepes) 
to pH 7.4, and supplemented with 10% decomplemented fetal 
calf serum, 100 U/ml penicillin, 100 pg/ml streptomycin, and 
2 mM glutamine. Then, they were plated onto plastic culture 
multidish wells (Costar, Cambridge, MA) and cultured at 37°C 
in 5% CO2 in air. Under such conditions, mesangial cells ap- 
peared after 7-14 days in culture and reached confluency by 
day 21. Cells were studied after 15-21 days of culture. 
The effects of TNF on PG and CAMP synthesis by mesangial 
cells were determined after addition of human recombinant 
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TNF (2 x 10’ U/mg; Genzyme, Boston, MA) to the culture 
medium (1 ml) of 12 multidish wells containing 150000-200000 
cells. When necessary, actinomycin D, cycloheximide, or in- 
domethacin (Sigma) were added together with TNF. 
2.2. Determination of PC synthesis by mesangial cells 
Radioimmunoassay of PGs was carried out in the culture 
medium of mesangial cells after extraction according to [lo]. 
PGs were assayed at four increasing dilutions. [‘H]PGEz, 
[“H]PGFh and [3H]6-keto-PGF1, were purchased from the 
Radiochemical Center (Amersham, UK). Anti-PGEz antibody 
was obtained from Institut Pasteur (Paris), anti-6-keto-PGFt, 
antibody was a gift from Dr Dunn (Cleveland, OH) and anti- 
PGFr, antibody had been raised in the laboratory. These an- 
tibodies cross-react only slightly with other PGs and could be 
considered as specific [ 111. 
2.3. Determination of cyclic AMP levels in the mesangial cell 
culture medium 
At the end of incubation, 0.2 ml of culture medium was 
removed, and added to 0.4 ml of an ice-cold ethanol/formic 
acid mixture (85 : 15, v/v) in order to extract CAMP. After 
30 min at 4°C. extracts were evaporated under nitrogen and the 
dry residues were resuspended in the radioimmunoassay buffer. 
Radioimmunoassay of CAMP was performed after acetylation 
of the samples, as described [6]. 
2.4. Statistical analysis 
The results are presented as means f SE. Where appropriate, 
degrees of statistical significance were determined by the paired 
Student t-test. 
3. RESULTS 
Different concentrations of TNF were added to 
the culture medium, and rat mesangial cells were 
incubated for 48 h (fig.la). Maximal stimulation 
of PGE2 production was observed after incubation 
with 100 ng/ml. To determine whether increased 
PGE2 synthesis resulted from a change in cell 
number, cell counts were also performed. Treat- 
ment with TNF for 48 h did not result in an in- 
crease of cell number at any of the concentrations 
used (fig.la). When the kinetics of PGE2 synthesis 
in response to TNF were examined, an increase 
first became apparent by 6 h after addition of TNF 
(100 ng/ml) and progressive additional increases 
occurred between 9 and 48 h (fig.lb). A decline in 
PGE2 production was then observed both in the 
presence and the absence of TNF. Similarly, TNF 
elicited a rise in the production of PGFh and 
6-keto-PGFr, (fig.2). Maximum effects of TNF 
also occurred at 100 ng/ml and for a 48-h incuba- 
tion period, but the percent increases above con- 
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Fig.1. Effect of TNF on PGEr synthesis (upper part) and cell 
growth (lower part). Incubations were carried out for 48 h (a). 
Time course of PGEz release from mesangial cells incubated 
without (0) and with (m) 100 ng/ml TNF (b). Means and SE of 
values obtained in 4-5 experiments are given. 
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Fig.2. Effect of TNF on PGFh (m) and 6-keto-PGF1, (0) 
synthesis. Incubations were carried out for 48 h. Means and SE 
of values obtained in 3 experiments are given. 
trol levels were slightly lower for PGFh and 
6-keto-PGF1, (6.5- and 3..5-fold control values, 
respectively) than for PGEz. Cell treatment by 
0.1 pg/ml actinomycin D, which inhibits RNA 
synthesis, did not significantly decrease basal 
PGE2 production, but reduced the stimulatory ef- 
fect of 100 ng/ml TNF by 80.8 f 7.2% (n = 4, P 
< 0.05). In addition, the stimulatory effect of TNF 
was inhibited by 60.6 + 4.6% in the presence of 
0.1 rg/ml cyclohexir&de, an inhibitor of protein 
Table 1 
Effect of actinomycin D and cycloheximide on PGE2 synthesis 
by mesangial cells 
Addition PGEz synthesis (ng/ml) 
Control TNF (100 ng/ml) 
None 5.73 * 2.14 35.62 f 6.20 
Actinomycin D (0.1 p&ml) 3.90 f 0.94 6.34 f 0.82* 
Cycloheximide (0.1 #g/ml) 1.38 f 2.85 16.51 f 5.75’ 
Mesangial cells were incubated for 48 h. The resulting 
mesangial supernatant was collected and assayed for PGEz 
concentration. Results arc expressed as means + SE of 4 
experiments. * P < 0.05, compared with values obtained 
without addition of drug 
synthesis (n = 4, P < 0.05) (table 1). The time 
course of CAMP concentration in the medium in 
the presence of TNF is shown in fig.3. A slight in- 
crease in CAMP concentration was detectable after 
9-12 h of TNF stimulation. This.was followed by 
a major peak of stimulation at 48 h which 
represented a 2-fold increase. To determine 
whether the observed effects were related to the in- 
creased production of PGs, studies utilizing a 
cyclooxygenase inhibitor (indomethacin, 10 ,uM) 
were also carried out. Addition of indomethacin 
reduced by 90% PGEz production by mesangial 
cells under basal conditions, and completely 
counteracted the stimulatory effect of TNF (table 
2). In parallel, indomethacin treatment caused a 
marked decrease of the basal values of CAMP, as 
well as a reduction of CAMP accumulation in 
response to TNF from + 0.822 f 0.037 to + 0.139 
+ 0.014 pmol/ml (n = 3, P c 0.005). However, the 
TNF-induced increase in CAMP levels remained 
statistically significant (P < 0.01). 
12 
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Fig.3. Time course of CAMP concentration in the culture 
medium of rat mesangial cells incubated with (B) and without 
(0) 100 ng/ml TNF. Means and SE of values obtained in 3 
experiments are given. 
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Table 2 
Effect of indomethacin on PGEz synthesis by mesangial cells and CAMP levels in their culture 
medium 
Addition PGEz synthesis (ng/ml) 
Control TNF (100 ng/ml) 
CAMP concentration (pmol/ml) 
Control TNF (100 ng/ml) 
None 5.94 + 1.31 30.52 f 5.08 0.642 + 0.049 1.464 f 0.082 
Indomethacin (10 ,uM) 0.52 + 0.09 0.43 f 0.06 0.145 + 0.066 0.283 f 0.073 
Mesangial cells were incubated for 48 h. The resulting mesangial supernatant was collected and 
assayed for both PGEz and CAMP concentrations. Results are expressed as means f SE of 3 
experiments, each performed in duplicate 
4. DISCUSSION 
Recent studies have demonstrated that TNF and 
IL-l, although being biochemically and im- 
munologically distinct proteins, share a number of 
similar biological activities [ 11. In nephrotoxic 
serum nephritis, both TNF and IL-l are released in 
glomeruli [2,3]. In contrast with the effects of 
IL-l, those of TNF on glomerular cells have never 
been reported. Our results demonstrate, for the 
first time, that recombinant human TNF 
stimulates PG and CAMP production by rat 
mesangial cells in culture. The stimulatory effect 
of TNF was dose dependent and affected the pro- 
duction of PGEz, PGFh and 6-keto-PGFr,, which 
are the major metabolites of the cyclooxygenase 
pathway in these cells [8]. A similar stimulation of 
PGE2 and PGI2 secretion has been observed 
previously in mesangial cells exposed to IL-l for 
24 h [12]. However, the time course of PG produc- 
tion which we observed in TNF-stimulated 
mesangial cells was not identical to that reported 
for mesangial cells stimulated by IL-l. After 1 h of 
incubation with IL-l, there was a significant in- 
crease in the production of PGE2 but a decrease in 
that of PGI2 whereas such a period of exposure to 
TNF was too short to alter the synthesis of these 
two PGs. The stimulatory effect of TNF on PG 
production thus required a long incubation period, 
as observed previously in other cell types including 
fibroblasts [ 13,141, resting macrophages [151 and 
osteoblast-like cells [16]. Such a lag-time suggests 
that RNA and protein synthesis are probably in- 
volved in the process of stimulating the cellular 
production of PGs. This hypothesis is supported in 
our study by the fact that actinomycin D and 
cycloheximide reduced the effect of TNF (table 1). 
Because TNF affects the generation of PGE2, 
PGFh and 6-keto-PGFr,, TNF-induced protein(s) 
would interfere with either cyclooxygenase or 
phospholipase activities. 
In mesangial cells incubated with TNF, the 
enhanced production of PGs was associated with 
an increase of CAMP concentration. These two 
events are linked since: (1) the time courses of 
PGE2 and CAMP accumulations exhibited similar 
patterns (fig.3); and (2) indomethacin completely 
abolished PGEz production and reduced CAMP ac- 
cumulation in response to TNF (table 2). However, 
a small but significant increase in CAMP was 
observed, even when TNF-induced PGE2 synthesis 
was suppressed by indomethacin, suggesting that 
other mechanisms are involved in this effect. 
Stimulations of PG production by mesangial 
cells incubated with TNF and of CAMP levels in 
their culture medium were not the result of altera- 
tions in cell number (fig.1). In fact, the mitogenic 
activity of TNF depends on the cell type since TNF 
appears to stimulate the growth of human 
fibroblasts [l] but not of osteoblast-like cells [16] 
and even to reduce the proliferation rate of en- 
dothelial cells [17]. However, TNF can affect the 
growth of mesangial cells under experimental con- 
ditions different from those we used, in particular 
when the cells are cultured in serum-free medium 
(not shown). 
In order to relate the significance of our obser- 
vations to in vivo situations it is necessary to 
estimate if the amount of TNF generated by 
monocytes/macrophages in glomeruli during 
nephrotoxic serum nephritis is sufficient to affect 
mesangial PG and CAMP syntheses. Wiggins et al. 
[3] have reported that the concentration of TNF 
released by glomeruli isolated on day 14 of this ex- 
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perimental model reached 410 U/ml per 1000 
glomeruli, which corresponds to a concentration 
of 20 ng/ml of recombinant TNF in our study. 
Since in vitro TNF effects were obtained for con- 
centrations between 1 and 100 ng/ml, the amount 
of TNF released by infiltrating macrophages at this 
stage of nephrotoxic serum nephritis is sufficient 
to increase the local production of PGs and con- 
centration of CAMP. 
Our present finding that TNF stimulates PG 
production by cultured mesangial cells and CAMP 
in their culture medium suggests that this cytokine 
released together with IL-l from inflammatory 
cells may play a pivotal role in modulating 
mesangial cell function in the course of 
glomerulonephritis. The finding that TNF 
stimulates CAMP levels, in part independently of 
its effect on PG production, suggests that this 
cytokine could act directly on CAMP synthesis or 
catabolism. 
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